Showing results (151-160 of 246) with videos related to
Sort By:
Pageof 25
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 13, 2022
Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patientsKatsuya Toshida, Shinji Itoh, Takahiro Tomiyama, et al.Langenbeck'S Archives of Surgery|February 17, 2021
Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinomaShoichi Inokuchi, Shinji Itoh, Tomoharu Yoshizumi, et al.International Journal of Clinical Oncology|September 14, 2021
Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastasesMizuki Ninomiya, Yasunori Emi, Takashi Motomura, et al.World Journal of Clinical Cases|June 12, 2019
Electrohydraulic lithotripsy and rendezvous nasal endoscopic cholangiography for common bile duct stone: A case reportKoichi Kimura, Kensuke Kudo, Tomoharu Yoshizumi, et al.Transplantation|June 19, 2018
Long-term Outcomes and Risk Factors After Adult Living Donor Liver TransplantationDaisuke Imai, Tomoharu Yoshizumi, Kazuhito Sakata, et al.Surgical Case Reports|April 10, 2016
Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case reportTakeshi Kurihara, Tomoharu Yoshizumi, Shinji Itoh, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 11, 2017
Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 yearsHideaki Uchiyama, Shinji Itoh, Tomoharu Yoshizumi, et al.Hepatology Communications|February 8, 2021
CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular CarcinomaKyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 13, 2018
Lymphocyte-to-Monocyte Ratio Is a Predictor of Survival After Liver Transplantation for Hepatocellular CarcinomaYohei Mano, Tomoharu Yoshizumi, Kyohei Yugawa, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 7, 2019
Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resectionDaisuke Imai, Takashi Maeda, Mototsugu Shimokawa, et al.Pageof 25